Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Short Interest Update

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) saw a large decline in short interest in December. As of December 31st, there was short interest totalling 10,400 shares, a decline of 62.6% from the December 15th total of 27,800 shares. Based on an average daily trading volume, of 273,300 shares, the short-interest ratio is currently 0.0 days.

Biodexa Pharmaceuticals Stock Up 2.3 %

Shares of BDRX stock traded up $0.10 on Wednesday, hitting $4.28. 3,434 shares of the company’s stock were exchanged, compared to its average volume of 13,708. Biodexa Pharmaceuticals has a 12 month low of $3.50 and a 12 month high of $74.00. The stock’s 50 day moving average is $4.58.

About Biodexa Pharmaceuticals

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.